Literature DB >> 8392840

Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells.

T Inoue1, K Fukuo, S Morimoto, E Koh, T Ogihara.   

Abstract

We examined the possible participation of nitric oxide (NO) in the activation of cyclooxygenase, a heme-containing enzyme, induced by interleukin-1 (IL-1) in vascular smooth muscle cells (VSMC). IL-1 induced a delayed and prolonged release of both NO and prostaglandin E2 (PGE2) from VSMC. NG-monomethyl-L-arginine (L-NMMA), an inhibitor of NO synthesis, partially but significantly inhibited the PGE2 release induced by IL-1, whereas it completely inhibited the IL-1-induced NO production. The inhibitory effects of L-NMMA on IL-1-induced production of both NO and PGE2 were partially reversed by a 10-fold excess of L-arginine. In addition, coincubation with superoxide dismutase enhanced the IL-1-induced PGE2 release from VSMC. In contrast, 8-bromo-cyclic GMP did not stimulate PGE2 release. Furthermore, 0.2 mM sodium nitroprusside directly stimulated PGE2 release from VSMC. These findings suggest that NO at least in part mediates the IL-1-induced PGE2 production, and that NO may be one of the important signals for the activation of cyclooxygenase to produce PGE2 in VSMC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392840     DOI: 10.1006/bbrc.1993.1836

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein.

Authors:  J E Barker; Y S Bakhle; J Anderson; T Treasure; P J Piper
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit.

Authors:  J L Bellot; M Palmero; C García-Cabanes; R Espí; C Hariton; A Orts
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

Review 3.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

4.  Regulation of prostaglandin production by nitric oxide; an in vivo analysis.

Authors:  D Salvemini; S L Settle; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

5.  Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors.

Authors:  D Salvemini; P T Manning; B S Zweifel; K Seibert; J Connor; M G Currie; P Needleman; J L Masferrer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

6.  Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Authors:  T A Swierkosz; J A Mitchell; T D Warner; R M Botting; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Estimation of nitric oxide as an inflammatory marker in periodontitis.

Authors:  K B Menaka; Amitha Ramesh; Biju Thomas; N Suchetha Kumari
Journal:  J Indian Soc Periodontol       Date:  2009-05

Review 8.  Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.

Authors:  Graciele Almeida de Oliveira; Robert Y S Cheng; Lisa A Ridnour; Debashree Basudhar; Veena Somasundaram; Daniel W McVicar; Hugo Pequeno Monteiro; David A Wink
Journal:  Antioxid Redox Signal       Date:  2016-10-31       Impact factor: 8.401

9.  Interleukin-1 beta stimulation of 45Ca2+ release from rat striatal slices.

Authors:  M Plami; M Frosini; G Sgaragli
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

10.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.

Authors:  J R Vane; J A Mitchell; I Appleton; A Tomlinson; D Bishop-Bailey; J Croxtall; D A Willoughby
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.